Parallax Volatility Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Hold |
0
| – | – | – | 1223 |
|
2023
Q2 | – | Sell |
-275
| Closed | -$3.69K | – | 1318 |
|
2023
Q1 | $3.69K | Sell |
275
-10,955
| -98% | -$147K | ﹤0.01% | 782 |
|
2022
Q4 | $139K | Sell |
11,230
-10,560
| -48% | -$131K | ﹤0.01% | 554 |
|
2022
Q3 | $304K | Buy |
+21,790
| New | +$304K | ﹤0.01% | 565 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 1631 |
|
2022
Q1 | – | Sell |
-125,000
| Closed | -$2.04M | – | 1586 |
|
2021
Q4 | $2.04M | Sell |
125,000
-16
| -0% | -$261 | ﹤0.01% | 230 |
|
2021
Q3 | $1.86M | Buy |
+125,016
| New | +$1.86M | ﹤0.01% | 256 |
|
2021
Q1 | – | Sell |
-50,638
| Closed | -$1.25M | – | 897 |
|
2020
Q4 | $1.25M | Buy |
50,638
+33,968
| +204% | +$839K | ﹤0.01% | 419 |
|
2020
Q3 | $691K | Buy |
16,670
+1,662
| +11% | +$68.9K | ﹤0.01% | 656 |
|
2020
Q2 | $719K | Buy |
15,008
+5,090
| +51% | +$244K | ﹤0.01% | 565 |
|
2020
Q1 | $624K | Buy |
9,918
+9,755
| +5,985% | +$614K | ﹤0.01% | 536 |
|
2019
Q4 | $20K | Sell |
163
-5,538
| -97% | -$680K | ﹤0.01% | 850 |
|
2019
Q3 | $378K | Buy |
5,701
+2,109
| +59% | +$140K | ﹤0.01% | 515 |
|
2019
Q2 | $286K | Buy |
3,592
+1,655
| +85% | +$132K | ﹤0.01% | 508 |
|
2019
Q1 | $217K | Buy |
1,937
+1,107
| +133% | +$124K | ﹤0.01% | 639 |
|
2018
Q4 | $84K | Buy |
+830
| New | +$84K | ﹤0.01% | 751 |
|
2018
Q3 | – | Sell |
-181
| Closed | -$15K | – | 2584 |
|
2018
Q2 | $15K | Buy |
+181
| New | +$15K | ﹤0.01% | 681 |
|
2018
Q1 | – | Sell |
-2,233
| Closed | -$130K | – | 3387 |
|
2017
Q4 | $130K | Buy |
+2,233
| New | +$130K | ﹤0.01% | 1531 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 2243 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 2524 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 2332 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 2239 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 2053 |
|
2016
Q1 | – | Sell |
-471
| Closed | -$70K | – | 2053 |
|
2015
Q4 | $70K | Buy |
+471
| New | +$70K | ﹤0.01% | 592 |
|